AMENDMENT NO. 1 TO THE MANUFACTURING AGREEMENTManufacturing Agreement • August 7th, 2015 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis AMENDMENT NO. 1 (this “Amendment No. 1”) to that certain MANUFACTURING AGREEMENT, dated as of September 30, 2014 (the “Agreement”), is hereby adopted as of August 5, 2015 (the “Amendment Effective Date”) by and between Anacor Pharmaceuticals, Inc. a company with its principal place of business at 1020 East Meadow Circle, Palo Alto, CA 94303 (“COMPANY”) and Hovione FarmaCiencia SA, a company with its principal place of business at Sete Casas, 2674-506 Loures, Portugal (“HOVIONE”). COMPANY and HOVIONE are sometimes referred to herein individually as a “Party” or together as the “Parties”. Capitalized terms used but not defined herein shall have the meanings such terms are given in the Agreement.
CONSULTING AGREEMENTConsulting Agreement • August 7th, 2015 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Consulting Agreement, dated as of May 31, 2015 (this “Agreement”), is made and entered into between Anacor Pharmaceuticals, Inc., a Delaware corporation (the “Service Recipient”), and Geoff Parker, an individual (the “Consultant”).
Re: Separation and Release Agreement (the “Agreement”)Separation and Release Agreement • August 7th, 2015 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Agreement confirms the termination of your employment with Anacor Pharmaceuticals, Inc. (the “Company”) and sets forth the agreement between you and the Company with respect thereto.
AMENDMENT TO THE DISTRIBUTION AND COMMERCIALIZATION AGREEMENTDistribution Agreement • August 7th, 2015 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis AMENDMENT TO THE DISTRIBUTION AND COMMERCIALIZATION AGREEMENT (this “Amendment”) is effective as of June 26, 2015 (the “Amendment Effective Date”) by and between ANACOR PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 1020 East Meadow Circle, Palo Alto, CA 94303 (“Anacor”) and SANDOZ INC., a Colorado corporation having its principal place of business at 100 College Road West, Princeton, NJ 08540 (“Sandoz”). Anacor and Sandoz are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein shall have the meanings such terms are given in the Agreement.